XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://finanza.primeconsult.it/coronavirus-moderna-chiede-lautorizzazione-per-il-suo-vaccino-in-europa-e-usa/60%Monthly2020-11-30 14:17
https://finanza.primeconsult.it/wired-trends-2021-la-trasformazione-digitale-accade-ora-ma-servono-pianificazione-formazione-e-cultura/60%Monthly2020-11-30 12:46
https://finanza.primeconsult.it/le-vibrazioni-del-coronavirus-possono-dirci-quanto-e-infettivo-e-mortale/60%Monthly2020-11-30 12:36
https://finanza.primeconsult.it/plasma-iperimmune-a-che-punto-siamo/60%Monthly2020-11-28 06:00
https://finanza.primeconsult.it/la-sperimentazione-del-vaccino-anti-covid-di-oxford-astrazeneca-e-da-rifare/60%Monthly2020-11-27 10:51
https://finanza.primeconsult.it/black-friday-tutte-ma-proprio-tutte-le-migliori-offerte-tech/60%Monthly2020-11-27 08:55
https://finanza.primeconsult.it/le-mutazioni-del-coronavirus-non-lo-hanno-reso-piu-contagioso/60%Monthly2020-11-27 06:20
https://finanza.primeconsult.it/la-francia-indichera-con-unetichetta-il-livello-di-riparabilita-dei-prodotti-tech/60%Monthly2020-11-26 09:27
https://finanza.primeconsult.it/perche-litalia-e-lunico-paese-deuropa-in-cui-non-si-usa-lautocertificazione-digitale/60%Monthly2020-11-26 06:00
https://finanza.primeconsult.it/uno-studio-dice-che-il-plasma-iperimmune-non-e-efficace-contro-il-coronavirus-nei-pazienti-gravi/60%Monthly2020-11-25 12:05
https://finanza.primeconsult.it/i-piccolissimi-robot-che-si-attivano-con-uno-spray/60%Monthly2020-11-25 11:26
https://finanza.primeconsult.it/qualche-questione-in-sospeso-sul-vaccino-anti-covid-di-oxford-e-astrazeneca/60%Monthly2020-11-24 13:50
https://finanza.primeconsult.it/bill-gates-vuole-vaccinare-tutto-il-mondo-contro-il-coronavirus/60%Monthly2020-11-24 11:19
https://finanza.primeconsult.it/quanto-sara-sicuro-il-vaccino-contro-il-nuovo-coronavirus-una-volta-approvato/60%Monthly2020-11-24 06:00
https://finanza.primeconsult.it/il-citofono-smart-e-il-nuovo-nemico-della-liberta/60%Monthly2020-11-24 06:00
https://finanza.primeconsult.it/per-essere-preparati-a-un-potenziale-virus-sars-cov-3-si-studia-lrna/60%Monthly2020-11-23 13:31
https://finanza.primeconsult.it/covid-19-arrivano-i-risultati-di-efficacia-anche-del-vaccino-di-oxford-astrazeneca/60%Monthly2020-11-23 11:25
https://finanza.primeconsult.it/come-sara-la-casa-del-futuro/60%Monthly2020-11-23 09:00
https://finanza.primeconsult.it/ma-liberaci-dal-malware-ora-il-vaticano-punta-sullintelligenza-artificiale/60%Monthly2020-11-23 06:11
https://finanza.primeconsult.it/quando-e-il-picco-dinfettivita-del-coronavirus/60%Monthly2020-11-23 06:00
https://finanza.primeconsult.it/quanto-sono-simili-covid-19-e-raffreddore/60%Monthly2020-11-21 06:00
https://finanza.primeconsult.it/il-coronavirus-sars-cov-2-circolava-in-italia-gia-prima-dellallarme-lanciato-dalla-cina-si-o-no/60%Monthly2020-11-20 13:50
https://finanza.primeconsult.it/coronavirus-come-funziona-la-procedura-di-approvazione-di-un-vaccino/60%Monthly2020-11-20 11:57
https://finanza.primeconsult.it/la-vaccinazione-contro-morbillo-parotite-e-rosolia-protegge-anche-da-covid-19/60%Monthly2020-11-20 11:00
https://finanza.primeconsult.it/non-solo-covid-tutto-quello-che-potremo-fare-con-i-vaccini-a-mrna/60%Monthly2020-11-20 06:00
https://finanza.primeconsult.it/cosa-ce-da-sapere-sullo-studio-che-mette-in-dubbio-lefficacia-delle-mascherine-per-chi-le-indossa/60%Monthly2020-11-19 13:33
https://finanza.primeconsult.it/covid-19-che-cose-la-nebbia-mentale-che-potrebbe-colpire-un-guarito-su-venti/60%Monthly2020-11-19 11:54
https://finanza.primeconsult.it/un-vaccino-non-e-solo-la-sua-efficacia/60%Monthly2020-11-19 06:00
https://finanza.primeconsult.it/e-terminata-la-sperimentazione-del-vaccino-di-pfizer-biontech-contro-covid-19/60%Monthly2020-11-18 16:33
https://finanza.primeconsult.it/coronavirus-limmunita-potrebbe-durare-mesi-ma-anche-anni/60%Monthly2020-11-18 11:45
https://finanza.primeconsult.it/la-console-modulare-per-insegnare-la-programmazione-ai-piu-piccoli/60%Monthly2020-11-18 10:00
https://finanza.primeconsult.it/cosa-sono-gli-inibitori-delle-jak-e-come-potrebbero-aiutarci-contro-covid-19/60%Monthly2020-11-18 06:00
https://finanza.primeconsult.it/controllare-i-droni-con-la-realta-aumentata/60%Monthly2020-11-17 10:41
https://finanza.primeconsult.it/i-vaccini-anti-covid-19-a-confronto/60%Monthly2020-11-17 06:39
https://finanza.primeconsult.it/covid-19-lannuncio-di-moderna-il-vaccino-efficace-al-945/60%Monthly2020-11-16 14:38
https://finanza.primeconsult.it/coronavirus-come-funziona-il-test-fai-da-te-del-veneto/60%Monthly2020-11-16 11:02
https://finanza.primeconsult.it/i-dubbi-sullo-studio-che-dice-che-il-coronavirus-e-arrivato-in-italia-nel-2019/60%Monthly2020-11-16 10:21
https://finanza.primeconsult.it/il-peso-di-covid-19-sul-cancro-ritardi-di-6-mesi-negli-screening-in-vari-paesi-europei/60%Monthly2020-11-14 06:00
https://finanza.primeconsult.it/ce-un-nuovo-assistente-digitale-vocale-e-chatbot-a-disposizione-delle-persone-diabetiche/60%Monthly2020-11-14 04:50
https://finanza.primeconsult.it/coronavirus-covid-19-malattia-infezione-un-glossario-per-capire-i-termini-dellepidemia/60%Monthly2020-11-13 13:05
https://finanza.primeconsult.it/covid-19-uno-spray-nasale-puo-proteggere-dal-contagio/60%Monthly2020-11-13 11:54
https://finanza.primeconsult.it/i-sintomi-del-long-covid-persistono-per-settimane-dopo-le-dimissioni/60%Monthly2020-11-12 15:12
https://finanza.primeconsult.it/3-punti-per-chi-pensa-che-lepidemia-di-coronavirus-stia-passando/60%Monthly2020-11-12 12:22
https://finanza.primeconsult.it/le-air-jordan-xi-che-si-autoallacciano/60%Monthly2020-11-12 10:29
https://finanza.primeconsult.it/coronavirus-quali-sono-i-luoghi-piu-a-rischio-di-contagio/60%Monthly2020-11-12 06:00
https://finanza.primeconsult.it/cosa-sappiamo-davvero-di-sputnik-v-il-vaccino-russo-contro-il-coronavirus/60%Monthly2020-11-11 15:16
https://finanza.primeconsult.it/i-prossimi-passi-dellitalia-per-farsi-trovare-pronta-allarrivo-del-vaccino/60%Monthly2020-11-11 06:01
https://finanza.primeconsult.it/e-stata-sospesa-unaltra-sperimentazione-di-un-vaccino-anti-covid/60%Monthly2020-11-10 11:50
https://finanza.primeconsult.it/un-altro-anticorpo-monoclonale-dopo-quello-di-trump-e-stato-approvato-per-uso-di-emergenza/60%Monthly2020-11-10 11:00
https://finanza.primeconsult.it/e-se-usassimo-solo-questi-due-parametri-per-decidere-le-regioni-da-chiudere/60%Monthly2020-11-10 06:00
https://finanza.primeconsult.it/covid-19-il-vaccino-pfizer-biontech-e-efficace-in-piu-del-90-dei-casi/60%Monthly2020-11-09 14:01
https://finanza.primeconsult.it/x-57-il-primo-velivolo-completamente-elettrico-della-nasa/60%Monthly2020-11-09 12:00
https://finanza.primeconsult.it/la-curva-dellaumento-dei-contagi-sta-davvero-rallentando/60%Monthly2020-11-09 11:50
https://finanza.primeconsult.it/lallarme-dellordine-dei-medici-serve-un-lockdown-totale/60%Monthly2020-11-09 11:22
https://finanza.primeconsult.it/lacquasantiera-digitale-che-misura-la-temperatura-e-sanifica-le-mani/60%Monthly2020-11-09 09:46
https://finanza.primeconsult.it/covid-19-dopo-la-guarigione-quasi-un-paziente-su-tre-perde-molti-capelli/60%Monthly2020-11-08 06:00
https://finanza.primeconsult.it/le-scuole-sono-davvero-un-rischio-in-questa-epidemia/60%Monthly2020-11-07 06:00
https://finanza.primeconsult.it/la-microscopica-star-trek-voyager-stampata-in-3d-che-puo-anche-muoversi/60%Monthly2020-11-06 16:51
https://finanza.primeconsult.it/la-danimarca-sta-abbattendo-milioni-di-visoni-per-stroncare-sul-nascere-un-potenziale-coronavirus-mutato/60%Monthly2020-11-06 13:00
https://finanza.primeconsult.it/coronavirus-lavorare-in-un-ufficio-puo-raddoppiare-il-rischio-di-contagio/60%Monthly2020-11-06 12:02
https://finanza.primeconsult.it/linquinamento-atmosferico-potrebbe-aumentare-i-decessi-per-coronavirus/60%Monthly2020-11-05 12:01
https://finanza.primeconsult.it/salute-e-sanita-come-potrebbero-essere-ripensate-in-italia-grazie-allai/60%Monthly2020-11-05 08:00
https://finanza.primeconsult.it/il-sistema-delle-regioni-rosse-arancioni-e-gialle-scricchiola-gia-in-partenza/60%Monthly2020-11-05 06:00
https://finanza.primeconsult.it/il-ruolo-della-superdiffusione-nella-pandemia-del-coronavirus/60%Monthly2020-11-04 14:17
https://finanza.primeconsult.it/le-cornee-sembrano-resistere-allinfezione-da-coronavirus/60%Monthly2020-11-04 11:32
https://finanza.primeconsult.it/il-coronavirus-continua-a-mutare-con-un-ceppo-forse-piu-contagioso/60%Monthly2020-11-03 13:45
https://finanza.primeconsult.it/esistono-7-diverse-forme-di-covid-19-lieve/60%Monthly2020-11-03 11:40
https://finanza.primeconsult.it/covid-19-per-i-bambini-un-nuovo-test-sulla-saliva-affidabile-quanto-il-tampone/60%Monthly2020-11-03 09:45
https://finanza.primeconsult.it/perche-in-lombardia-lepidemia-di-covid-19-ha-colpito-di-piu/60%Monthly2020-11-03 05:55
https://finanza.primeconsult.it/come-cambiera-la-silicon-valley-dopo-le-elezioni-presidenziali-americane/60%Monthly2020-11-02 09:30
https://finanza.primeconsult.it/alcuni-pazienti-covid-19-sviluppano-anticorpi-che-attaccano-lorganismo/60%Monthly2020-11-01 06:00